Lunai Bioworks Inc.
LNAI
$2.27
-$0.02-0.87%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 20.90K | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 20.90K | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 20.90K | -- | -- | -- | -- |
| SG&A Expenses | 9.60M | 12.40M | 14.99M | 17.88M | 18.88M |
| Depreciation & Amortization | 96.40K | 117.40K | 138.20K | 129.10K | 127.60K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.86M | 12.58M | 15.30M | 18.55M | 19.90M |
| Operating Income | -9.84M | -12.58M | -15.30M | -18.55M | -19.90M |
| Income Before Tax | -128.28M | -125.52M | -130.98M | -178.01M | -67.01M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -128.28 | -125.52 | -130.98 | -178.01 | -67.01 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -128.28M | -125.52M | -130.98M | -178.01M | -67.01M |
| EBIT | -9.84M | -12.58M | -15.30M | -18.55M | -19.90M |
| EBITDA | -9.74M | -12.46M | -15.16M | -18.42M | -19.77M |
| EPS Basic | -58.00 | -57.09 | -60.06 | -83.17 | -33.95 |
| Normalized Basic EPS | -2.51 | -3.54 | -4.57 | -5.83 | -6.98 |
| EPS Diluted | -58.00 | -57.09 | -60.06 | -83.17 | -34.01 |
| Normalized Diluted EPS | -2.51 | -3.53 | -4.56 | -5.81 | -6.97 |
| Average Basic Shares Outstanding | 11.08M | 9.98M | 9.07M | 8.25M | 7.94M |
| Average Diluted Shares Outstanding | 11.08M | 10.00M | 9.09M | 8.27M | 7.96M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |